CAPR Overview
Upcoming Projects (CAPR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CAPR)
-
Analyzing Capricor's Mid-Cycle Review Update for Deramiocel in Duchenne Muscular Dystrophy Cardiomyopathy
Tickers: CAPR, SRPT
Executed On: Jul 18, 2025 at 02:00 PM EDT
Upcoming & Overdue Catalysts (CAPR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CAPR)
-
Phase 2 six month data of CAP-1002 ALLSTAR trial for Myocardial infarction (heart attack) due 1Q 2017
Ticker: CAPR
Occurred on: May 12, 2017 -
Phase 1/2 data of CAP-1002 HOPE-Duchenne trial for DMD
Ticker: CAPR
Occurred on: Apr 25, 2017 -
Capricor (CAPR) Announces 12 Month Phase 1 DYNAMIC Data Evaluating CAP-1002 in Advanced Heart Failure
Ticker: CAPR
Occurred on: Oct 31, 2016 -
Capricor Therapeutics Completes Enrollment in Randomized HOPE Clinical Trial in Duchenne Muscular Dystrophy
Ticker: CAPR
Occurred on: Sep 07, 2016 -
Capricor Awarded $3.4 Million Grant from California Institute for Regenerative Medicine
Ticker: CAPR
Occurred on: Mar 17, 2016
Strategic Initiatives (CAPR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
